Adverum Biotechnologies, Inc. (ADVM) Social Stream



Adverum Biotechnologies, Inc. (ADVM): $1.18

0.01 (+0.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ADVM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 397

in industry

Adverum Biotechnologies Inc (ADVM) Price Targets From Analysts

Use the tables below to see what analysts covering Adverum Biotechnologies Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 6 $13 $3 $6 $1.34 347.76%
2022-03-30 3 $6 $4 $5 $1.34 273.13%

The Trend in the Analyst Price Target


Over the past 51 weeks, ADVM's average price target has gone down $19.89.

ADVM reports an average of 115.79% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-15 10 23 4 7.880 3.60 118.89%
2021-09-20 9 6 2 3.570 2.24 59.37%
2021-11-05 4 6 3 4.333 2.20 96.95%
2021-11-05 6 13 3 6.000 2.20 172.73%
2021-11-05 4 6 3 4.250 2.20 93.18%

ADVM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 1 0 2 0 0 3

The Trend in the Broker Recommendations


Over the past 30 weeks, ADVM's average broker recommendation rating improved by 0.56.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Adverum Biotechnologies Inc's average analyst price target is greater than 12.95% of all US stocks.
  • In terms of how Adverum Biotechnologies Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 454.99% of that group.
  • In the context of stocks in the small market cap category, Adverum Biotechnologies Inc's variance in analysts' estimates is lower than -292.61% of them.
  • Adverum Biotechnologies Inc's number of analysts covering the stock is higher than 289.57% of stocks in the small market cap category.

Stocks similar to Adverum Biotechnologies Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ADMA, ADAP, and ACOR.

Make investment decisions regarding ADVM using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4476 seconds.